Bottom line
How much do ARKG and HELX overlap?
26% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 34.7% of ARKG's assets and 31.8% of HELX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings ARKG and HELX have in common
| Holding | % of ARKG | % of HELX | Overlap |
|---|---|---|---|
| Twist Bioscience Corp TWST | 7.73% | 2.85% | 2.85% |
| Tempus Ai Inc TEM | 6.56% | 1.95% | 1.95% |
| Guardant Health Inc GH | 4.74% | 9.09% | 4.74% |
| Eli Lilly & Company LLY | 4.68% | 2.95% | 2.95% |
| Natera Inc NTRA | 4.13% | 7.46% | 4.13% |
| Adaptive Biotechnologies Corp ADPT | 2.57% | 3.99% | 2.57% |
| Veracyte Inc VCYT | 2.55% | 1.64% | 1.64% |
| Ionis Pharmaceuticals Inc IONS | 1.77% | 1.91% | 1.77% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in ARKG
- 10x Genomics Inc — 9.39%
- Crispr Therapeutics Ag — 6.29%
- Personalis Inc — 5.47%
- Absci Corp — 5.14%
- Illumina Inc — 4.74%
- Caredx Inc — 4.30%
- Beam Therapeutics Inc — 3.78%
- Compass Pathways Plc — 3.25%
- Recursion Pharmaceuticals Inc — 2.63%
- Nurix Therapeutics Inc — 2.51%
- Butterfly Network Inc — 2.18%
- Schrodinger Inc — 1.99%
- Genedx Holdings Corp — 1.87%
- Intellia Therapeutics Inc — 1.83%
- Alamar Biosciences Inc — 1.56%
Only in HELX
- Krystal Biotech Inc — 6.33%
- Ligand Pharmaceuticals Inc — 4.62%
- United Therapeutics Corp — 3.51%
- Bridgebio Pharma Inc — 3.50%
- Vertex Pharmaceuticals Inc — 2.75%
- Astrazeneca Plc — 2.70%
- Travere Therapeutics Inc — 2.59%
- Insmed Inc — 2.44%
- Samsung Biologics Co Ltd — 2.26%
- Corteva Inc — 2.25%
- Medpace Holdings Inc — 2.15%
- Alnylam Pharmaceuticals Inc — 1.96%
- Neurocrine Biosciences Inc — 1.84%
- Regeneron Pharmaceuticals Inc — 1.80%
- Argenx Se — 1.64%
Asset mix
| Asset type | ARKG | HELX |
|---|---|---|
| Stocks | 99.6% | 97.9% |
| Preferred stock | — | 0.9% |
| Cash & short-term funds | 0.2% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | ARKG | HELX |
|---|---|---|
| US | 90.3% | 86.6% |
| CH | 6.3% | 1.2% |
| GB | 3.3% | 3.0% |
| KR | — | 2.6% |
| DE | — | 2.2% |
| NL | — | 2.1% |
| IE | — | 0.8% |
| SG | — | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do ARKG and HELX overlap?
What stocks do ARKG and HELX have in common?
Should I own both ARKG and HELX?
Which holds more stocks, ARKG or HELX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.